DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Bush ZM, Longtine JA, Cunningham T. et al.
Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression.
J Clin Endocrinol Metab 2010;
95: E280-E290
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.